02633 JACOBSON PHARMA
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 03/2025) | |||
| Current | 1.88X | Oper Margin | 26.3% |
|---|---|---|---|
| LT Debt/Equity | 20.9% | Net Margin | 19.1% |
| Total Debt/Equity | 31.5% | Return on Equity | 12.3% |
| Price/Book | 1.37X | Return on Assets | 8.3% |
| (HKD 1.680) | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
| Net Profit (MHKD) | 300.83 | 266.97 | 251.04 | 177.67 | 173.71 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +12.7 | +6.3 | +41.3 | +2.3 | -19.4 |
| Earnings Per Share (HKD) | 0.152 | 0.139 | 0.131 | 0.093 | 0.091 |
| Earnings Per Share Growth (%) | +9.0 | +5.9 | +41.6 | +2.2 | -16.6 |
| Dividend Per Share (HKD) | 0.150 | 0.055 | 0.052 | 0.039 | 0.023 |
| P/E* (X) | 11.09 | 12.09 | 12.80 | 18.12 | 18.52 |
| Yield (%) | 8.93 | 3.27 | 3.08 | 2.31 | 1.37 |
| Dividend Share (%) | 99.01 | 39.57 | 39.45 | 41.86 | 25.36 |
| Book NAV (HKD) | 1.227 | 1.186 | 1.435 | 1.301 | 1.248 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (HKDMn) | 2025-03 | 2024-03 | Chg* (%) | 2023-03 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,577 | 1,710 | -7.8 | 1,786 |
| Operating Result | 376.589 | 346.117 | +8.8 | 337.964 |
| Associates | 0.398 | -0.437 | -191.1 | -3.56 |
| Profit Before Taxation | 373.626 | 347.245 | +7.6 | 339.755 |
| Taxation | 72.793 | 56.467 | +28.9 | 56.546 |
| Profit /( Loss) After Taxation | 300.833 | 290.778 | +3.5 | 283.209 |
| Minority Interests | 0 | 23.81 | -100.0 | 32.165 |
| Net Profit | 300.833 | 266.968 | +12.7 | 251.044 |
| Earnings Per Share () | 0.1515 | 0.1390 | +9.0 | 0.1313 |
| Dividend Per Share () | 0.1500 | 0.0550 | +172.7 | 0.0518 |
| Announcement Date | 2025-06-13 | 2024-06-20 | NA | 2023-06-15 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
